Abstract
Granulocyte macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and interleukin-5 (IL-5 belong to a family of cytokines that regulate proliferation, differentiation and function of haematopoietic cells. Their receptor consists of a ligand specific α-chain and a signal transducing β-chain (βc). While, the role of phosphotyrosine residues in the βc as mediators of downstream signalling cascades has been established, little is known about non-phosphotyrosine mediated events. To identify proteins interacting with βc, we screened a yeast two-hybrid library with the intracellular domain of βc. We found that RACK1, a molecule associating with activated PKC, PLCγ and Src kinases, associated with the membrane proximal region of βc in both yeast two-hybrid, immunoprecipitation and GST-pull-down assays. The association of RACK1 was constitutive, demonstrating no alteration upon cellular stimulation. Furthermore, upon stimulation of cells with IL-5 or PMA, a complex of βc and PKCβ was found. Together, these findings suggest a novel role for RACK1 as a possible adapter molecule associating with the intracellular domain of cytokine receptors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Al-Shami A, Bourgoin SG and Naccache PH. . 1997 Blood 89: 1035–1044.
Baxter GT, Miller D, Kuo KC, Wada G and Owicki J. . 1992 Biochemistry 31: 10950–10954.
van der Bruggen T, Kok PTM, Raaijmakers JAM, Verhoeven AJ, Kessels RGC, Lammers J-WJ and Koenderman L. . 1993 J. Leukocyte Biol. 53: 347–353.
Burton EA, Hunter S, Wu SC and Anderson SM. . 1997 J. Biol. Chem. 272: 16189–16195.
Caldenhoven E, van Dijk T, Raaijmakers JAM, Lammers JWJ, Koenderman L and de Groot RP. . 1995 J. Biol. Chem. 270: 25778–25784.
Chang BY, Conroy KB, Machleder EM and Cartwright CA. . 1998 Mol. Cell. Biol. 18: 3245–3256.
Chihara J, Plumas J, Gruart V, Tavernier J, Prin L, Capron A and Capron M. . 1990 J. Exp. Med. 172: 1347–1351.
Chin H, Nakamura N, Kamiyama R, Miyasaka N, Ihle JN and Miura O. . 1996 Blood 88: 4415–4425.
Cloud-Heflin BA, McMasters RA, Osborn MT and Chambers TC. . 1996 Eur. J. Biochem. 239: 796–804.
Eder M, Griffin JD and Ernst TJ. . 1993 EMBO J. 12: 1647–1656.
Fujisawa T, Abu Ghazaleh R, Kita H, Sanderson CJ and Gleich GJ. . 1990 J. Immunol. 144: 642–646.
Gale RE, Freeburm RW, Khwaja A, Chopra R and Linch DC. . 1998 Blood 91: 54–63.
de Groot RP, van Dijk TB, Caldenhoven E, Coffer PJ, Raaijmakers JAM, Lammers J-WJ and Koenderman L. . 1997 J. Biol. Chem. 272: 2319–2325.
de Groot RP, Coffer PJ and Koenderman L. . 1998 Cell. Signal. 10: 619–628.
Gubina E, Rinaudo MS, Szallasi Z, Blumberg PM and Mufson RA. . 1998 Blood 91: 823–829.
Lanfrancone L, Pelicci G, Brizzi MF, Aronica MG, Casciari C, Giuli S, Pegorado L, Pawson T and Pellici PG. . 1995 Oncogene 10: 907–917.
Li Y, Shen BF, Karanes C, Sensenbrenner L and Chen B. . 1995 J. Immunol. 155: 2165–2174.
Liliental J and Chang DD. . 1998 J. Biol. Chem. 273: 2379–2383.
Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG and Valdas MA. . 1988 J. Exp. Med. 167: 219–224.
Malizewski CR, March CJ, Schoenborn MA, Gimpel S and Shen L. . 1990 J. Exp. Med. 172: 1665–1672.
Murakami M, Narazaki M, Hibi M, Yawata H, Yasukawa K, Hamaguchi M, Taga T and Kishimoto T. . 1991 Proc. Natl. Acad. Sci. USA 88: 11349–11353.
Murata Y, Takaki S, Migita M, Kikuchi Y, Tominaga A and Takatsu K. . 1992 J. Exp. Med. 175: 341–351.
Padanilam BJ and Hammerman MR. . 1997 Am. J. Physiol. 272: F160–F166.
Pascale A, Fortino I, Govoni S, Trabucci M, Wetsel WC and Battaini F. . 1996 J. NeuroChem. 67: 2471–2477.
Pierce A, Heyworth CM, Nicholls SE, Spooncer E, Dexter TM, Lord JM, Owen-Lynch PJ, Wark G and Whetton AD. . 1998 J. Cell. Biol. 140: 1511–1518.
Quelle FW, Sato N, Witthuhn BA, Inhorn RC, Eder M, Miyajima A, Griffin JD and Ihle JN. . 1994 Mol. Cell. Biol. 14: 4335–4341.
Rinaudo MS, Su K, Falk LA, Haldar S and Mufson RA. . 1995 Blood 86: 80–88.
Ron D, Chen CH, Caldwell J, Jamieson L, Orr E and Mochly-Rosen D. . 1994 Proc. Natl. Acad. Sci. USA 91: 839–843.
Ron D, Luo J and Mochly-Rosen D. . 1995a J. Biol. Chem. 270: 24180–24187.
Ron D and Mochly-Rosen D. . 1995b Proc. Natl. Acad. Sci. USA 92: 492–496.
Rossi F, McNagny KM, Smith G, Frampton J and Graf T. . 1996 EMBO J. 15: 1894–1901.
Sanderson CJ, Warren DJ and Strath M. . 1985 J. Exp. Med. 162: 60–74.
Spaargaren M and Bischoff JR. . 1994 Proc. Natl. Acad. Sci. USA 91: 12609–12613.
Tavernier J, Devos R, Cornelis S, Tuypens T, van der Heyden J, Fiers W and Plaetinck G. . 1991 Cell 66: 1175–1184.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Geijsen, N., Spaargaren, M., Raaijmakers, J. et al. Association of RACK1 and PKCβ with the common β-chain of the IL-5/IL-3/GM-CSF receptor. Oncogene 18, 5126–5130 (1999). https://doi.org/10.1038/sj.onc.1202896
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202896
Keywords
This article is cited by
-
Identification of a new Mpl-interacting protein, Atp5d
Molecular and Cellular Biochemistry (2014)
-
RACK1, A multifaceted scaffolding protein: Structure and function
Cell Communication and Signaling (2011)
-
Tumor-mediated inhibition of dendritic cell differentiation is mediated by down regulation of protein kinase C beta II expression
Immunologic Research (2010)
-
Function of p73, not of p53, is inhibited by the physical interaction with RACK1 and its inhibitory effect is counteracted by pRB
Oncogene (2003)